- Home
- IBP vs GRFS Comparison
IBP vs GRFS Comparison
Compare IBP & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- GRFS
- Stock Information
- Founded
- IBP 1977
- GRFS 1940
- Country
- IBP United States
- GRFS Spain
- Employees
- IBP N/A
- GRFS N/A
- Industry
- IBP Homebuilding
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- IBP Consumer Discretionary
- GRFS Health Care
- Exchange
- IBP Nasdaq
- GRFS Nasdaq
- Market Cap
- IBP 4.8B
- GRFS 5.1B
- IPO Year
- IBP 2014
- GRFS 2006
- Fundamental
- Price
- IBP $173.69
- GRFS $6.66
- Analyst Decision
- IBP Buy
- GRFS
- Analyst Count
- IBP 11
- GRFS 0
- Target Price
- IBP $226.00
- GRFS N/A
- AVG Volume (30 Days)
- IBP 376.1K
- GRFS 1.2M
- Earning Date
- IBP 05-08-2025
- GRFS 01-01-0001
- Dividend Yield
- IBP 1.88%
- GRFS N/A
- EPS Growth
- IBP 5.69
- GRFS 283.33
- EPS
- IBP 9.10
- GRFS 0.24
- Revenue
- IBP $2,941,300,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- IBP $0.81
- GRFS $8.45
- Revenue Next Year
- IBP $5.09
- GRFS $7.08
- P/E Ratio
- IBP $18.20
- GRFS $35.63
- Revenue Growth
- IBP 5.86
- GRFS 9.41
- 52 Week Low
- IBP $159.76
- GRFS $5.79
- 52 Week High
- IBP $281.04
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- IBP 39.44
- GRFS 36.64
- Support Level
- IBP $165.23
- GRFS $6.90
- Resistance Level
- IBP $176.98
- GRFS $7.56
- Average True Range (ATR)
- IBP 5.68
- GRFS 0.23
- MACD
- IBP -0.56
- GRFS -0.10
- Stochastic Oscillator
- IBP 21.84
- GRFS 2.96
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.